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Abstract
Moyamoya phenomenon is a term used to describe extensive collateralization of the circle of Willis
arteries associated with severe unilateral or bilateral internal carotid artery stenosis or occlusion
in the presence of certain conditions. Down syndrome is among these conditions. A case is
reported of a young girl with Down syndrome who presented with fluctuating right-sided weakness
and facial droop found to have cerebral ischemia. Subsequent investigations disclosed characteristic
"puff of smoke" patterns on angiographic studies consistent with moyamoya phenomenon. The
patient was initially treated with aspirin and eventually underwent an encephalomyosynangiosis.
This young patient with Down syndrome and moyamoya phenomenon serves as a reminder of the
association between these two conditions.
Background
Moyamoya disease is a nonatherosclerotic and nonin-
flammatory condition characterized by progressive steno-
sis of the terminal internal carotid artery and the proximal
portions of the anterior cerebral and middle cerebral arter-
ies. The term "moyamoya disease" is used when the inter-
nal carotid artery stenosis and associated collaterals are
observed bilaterally and when no associated diseases are
identified. "Moyamoya phenomenon" is used to describe
the extensive collateralization of the circle of Willis arter-
ies associated with severe unilateral or bilateral internal
carotid artery stenosis or occlusion in the presence of cer-
tain conditions. Clinical presentation is variable and age
dependent, with risk of hemorrhage increasing with age
and ischemic symptoms predominate in the young [1].
There have been published case reports of the co-occur-
rence of both moyamoya and Down syndrome, but
knowledge regarding the etiology is sparse.
Case presentation
A 4 and 1/2 year old Mexican girl with Down syndrome
presented to the emergency department of a local tertiary
care center with symptoms of fluctuating right arm weak-
ness and difficulty smiling that started approximately 4
hours before admission. Her parents found her in bed that
morning and noted that she had difficulty playing with
one of her dolls because she kept dropping them with her
right hand. Her smile also seemed a bit "twisted" accord-
ing to her mother, and she walked with a limp on her right
leg. There was no reported headache or vomiting nor did
the child have any history of seizures.
On examination she was normotensive and afebrile. The
child was sitting comfortably on the stretcher with her
mother present beside her. The child had typical facial
characteristics of trisomy 21. Her speech was delayed. Cra-
nial nerve testing revealed a mild right-sided lower facial
droop. Motor testing revealed a fluctuating 4+/5 MRC
(Medical Research Council) Grade strength of her right
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signs included an equivocal right toe and a down-going
left toe. She walked towards her mother with a slight limp
favoring the right side.
Routine laboratory serum studies were unremarkable. Ini-
tial head computed tomography did not reveal any acute
findings. Subsequent magnetic resonance angiography
and imaging revealed acute ischemic changes in the left
temporal-parietal area with left middle cerebral artery col-
lateralization (see Figures 1 and 2, respectively).
The differential diagnosis included transient ischemic
attacks, ischemic stroke, dissection, hypoglycemia, cardiac
source emboli, hypercoaguable states, seizures, and
migraines [1].
The patient was given aspirin 81 mg po qd and physical
therapy. She was discharged home and eventually under-
went an an encephalomyosynangiosis.
Her initial outcome post-operatively was satisfactory but
unfortunately she was lost to follow-up.
Discussion
Moyamoya disease is a noninflammatory, non-vasculitic
and nonatherosclerotic condition characterized by pro-
gressive stenosis of intracranial arteries. The intracranial
arteries usually involved are the terminal internal carotid
artery and the proximal portions of the anterior cerebral
and middle cerebral arteries. There is a slowly progressive
occlusion which permits the development of the unique
small anastomotic collateral pathways causing the "puff
of smoke" appearance on the angiogram or "cerebral
basal rete mirabile". Moyamoya disease is the term used
when the internal carotid artery stenosis and associated
collaterals are observed bilaterally and when no associ-
ated diseases are identified (i.e., idiopathic). Moyamoya
phenomenon is the term used to describe extensive collat-
eralization of the circle of Willis arteries associated with
severe unilateral or bilateral internal carotid artery steno-
sis or occlusion in the presence of certain conditions [1].
The list of conditions and causes associated with
moyamoya phenomenon is long an includes neurofi-
bromatosis, craniopharyngioma, optic glioma, distal
internal carotid artery compression by tumor, chronic
meningitis, leptospiral infections, atherosclerosis, sickle
cell disease, antiphospholipid syndrome or lupus antico-
agulant, Alagille syndrome (an autosomal dominant dis-
order associated with abnormalities of the liver, heart,
skeleton, eye, and kidneys and characteristic facial mor-
phology, osteogenesis imperfecta, Costello syndrome (a
rare genetic disorder that affects multiple organs), and
cocaine use. Moyamoya phenomenon has also been asso-
ciated with extracranial and peripheral arterial disease,
essential thrombocythemia, and birth control pills (possi-
bly in combination with cigarettes). Cases of moyamoya
vessels developing around the stenosis of a vessel supply-
ing an arteriovenous malformation have been reported.
Recent case reports suggest an association between thyro-
toxicosis (Grave disease) and severe moyamoya disease
[Please see reference 1 for an excellent review].
Moyamoya was first described in the late 1950's with most
cases being reported from Japan. Clinical presentation is
Magnetic resonance imaging obtained the day after admission demonstrating cute ischemia in th  left temporal and pari-et l area (horizo tal gr y bar)Figur  1
Magnetic resonance imaging obtained the day after 
admission demonstrating acute ischemia in the left 
temporal and parietal area (horizontal gray bar).
Magnetic resonance angiogram study obtained the day after admission demo str ting p o inent c llaterals and occlu-sions in th  region of the middle cerebral arteries also involv-ing th  supraclinoid region (horizontal gr y ba )Fi ure 2
Magnetic resonance angiogram study obtained the 
day after admission demonstrating prominent collat-
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be ischemic, whereas in adults they are more often hem-
orrhagic. It occurs with a bimodal onset, peaking in the
first and fourth decades of life. Children are more likely to
present with acute transitory hemiplegia secondary to
recurrent cerebrovascular episodes [2]. Down syndrome
in association with moyamoya has been reported since
the 1980's and ischemic vascular pathologies in general
are common. Infact, new-onset focal weakness is not
uncommon in Down syndrome and moyamoya syn-
drome is one of the more common causes [3].
The exact etiology of moyamoya is unknown. It has been
speculated that there is a genetic mode of inheritance
based on a higher incidence of the disease in Asian popu-
lations and on familial occurrence in both Asians and
whites and this has been supported by genetic linkage
analysis. Various connective tissue, angiogenesis, and
inflammatory mediators have been implicated including
fibroblast growth factor, transforming growth factor β1,
elastin, and prostaglandin E2 [4].
The association of moyamoya with Down syndrome is
also not fully understood. The incidence of moyamoya
syndrome in patients with trisomy 21 is approximately
three times the general population [5]. Moyamoya is char-
acterized by elastopathic vascular damage, and patients
with Down syndrome are in general predisposed to vascu-
lar diseases, including abnormal nail bed capillary mor-
phology, high pulmonary vascular resistance, retinal
vessel abnormalities, renovascular hypertension, and pri-
mary intimal fibroplasias [5,6]. There has also been a
reported association of elastosis perforans serpiginosa (a
dermatologic disease characterized by transepithelial
elimination of abnormal elastic fibers, and focal dermal
elastosis) with both Down syndrome and moyamoya [7].
Chromosome 21 encodes proteins that affect arterial
physiology and elasticity, including superoxide dismutase
1, interferon γ receptor, cystathionine β-synthetase, and
collagen type IV (found in the intima of large arteries). It
has been postulated that these proteins may be abnor-
mally expressed when three copies of chromosome 21 are
present [2]. Pathologic studies are limited but support this
notion [8].
Various treatments have been explored, although none
are ideal. Medical therapy in ischemic moyamoya condi-
tions include aspirin and hydration [2]. Surgical treatment
includes both direct and indirect revascularization proce-
dures, and one review concludes no difference between
the two techniques [9]. The largest and most recent study
to date of long-term outcome of surgical revascularization
in Downs syndrome patients with moyamoya (ages rang-
ing from 1 to 29 years old) suggests that clinical, radio-
logic, and angiographic features of moyamoya
phenomenon associated with Down syndrome are com-
parable to those of idiopathic moyamoya disease. Cere-
bral revascularization surgery with the pial synangiosis
technique seems to confer long-lasting protection against
additional strokes in this patient population [10].
In summary, the presence of moyamoya syndrome should
be considered in the evaluation of patients with Down
syndrome who present with transient ischemic attack-like
symptoms of fluctuating hemiparesis even in the very
young. Surgical revascularization with encephalomyosy-
nangiosis apparently confers long-term benefits.
Conclusion
The presence of moyamoya syndrome should be consid-
ered in the evaluation of patients with Down syndrome
who present with transient ischemic attack-like symptoms
of fluctuating hemiparesis even in the very young. Surgical
revascularization with encephalomyosynangiosis may
confer long-term benefits.
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